Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2023
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+7.13%
|
-
|
|
Jul 15
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.98%
|
-
|
|
Jul 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+1.54%
|
-
|
|
Jun 30
2023
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,851
+50.0%
|
-
|
|
Jun 15
2023
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-5.02%
|
$15,799
$37.86 P/Share
|
|
Jun 15
2023
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+12.65%
|
-
|
|
Jun 15
2023
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,346
-14.89%
|
$49,802
$37.86 P/Share
|
|
Jun 15
2023
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,879
+35.05%
|
-
|
|
Jun 15
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.98%
|
-
|
|
Jun 15
2023
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
2,766
-39.57%
|
$102,342
$37.55 P/Share
|
|
Jun 14
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,531
+44.75%
|
-
|
|
Jun 14
2023
|
Vijaya Gadde Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,531
+31.46%
|
-
|
|
Jun 14
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,531
+44.17%
|
-
|
|
Jun 14
2023
|
Samir Kaul Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,531
+32.66%
|
-
|
|
Jun 14
2023
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,703
+42.96%
|
-
|
|
Jun 09
2023
|
Kumud Kalia Chief Information Officer |
BUY
Open market or private purchase
|
Direct |
2,981
+23.02%
|
$95,392
$32.73 P/Share
|
|
Jun 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+4.33%
|
-
|
|
Jun 01
2023
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-0.86%
|
$3,410
$31.39 P/Share
|
|
Jun 01
2023
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
316
+2.42%
|
-
|
|
Jun 01
2023
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-10.01%
|
$7,626
$31.39 P/Share
|
|
Jun 01
2023
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+22.41%
|
-
|
|
Jun 01
2023
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
55
-0.23%
|
$1,705
$31.39 P/Share
|
|
Jun 01
2023
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
158
+0.66%
|
-
|
|
Jun 01
2023
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.5%
|
$2,821
$31.39 P/Share
|
|
Jun 01
2023
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+1.43%
|
-
|
|
May 15
2023
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-20.91%
|
$34,722
$27.89 P/Share
|
|
May 15
2023
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,718
+37.68%
|
-
|
|
May 15
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+4.97%
|
-
|
|
May 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+4.52%
|
-
|
|
Apr 15
2023
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+5.31%
|
-
|
|
Apr 15
2023
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,692
-8.9%
|
$88,608
$24.5 P/Share
|
|
Apr 15
2023
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,568
+25.97%
|
-
|
|
Apr 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+4.81%
|
-
|
|
Mar 15
2023
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-18.96%
|
$44,278
$26.78 P/Share
|
|
Mar 15
2023
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,931
+35.44%
|
-
|
|
Mar 15
2023
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,600
+0.42%
|
$223,600
$26.15 P/Share
|
|
Mar 15
2023
|
Myrtle S Potter Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+5.53%
|
-
|
|
Mar 14
2023
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
84,452
+3.97%
|
$2,195,752
$26.33 P/Share
|
|
Mar 14
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
8,500
+14.91%
|
$221,000
$26.4 P/Share
|
|
Mar 14
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,500
+0.44%
|
$221,000
$26.4 P/Share
|
|
Mar 13
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
40,000
+45.51%
|
$1,000,000
$25.41 P/Share
|
|
Mar 13
2023
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+1.05%
|
$1,000,000
$25.41 P/Share
|
|
Mar 04
2023
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+4.98%
|
-
|
|
Mar 03
2023
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
6,500
-83.75%
|
$201,500
$31.92 P/Share
|
|
Mar 01
2023
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-3.07%
|
$7,134
$29.36 P/Share
|
|
Mar 01
2023
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
711
+8.16%
|
-
|
|
Mar 01
2023
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.77%
|
$3,132
$29.36 P/Share
|
|
Mar 01
2023
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+1.83%
|
-
|
|
Mar 01
2023
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.28%
|
$1,885
$29.36 P/Share
|
|
Mar 01
2023
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
157
+0.67%
|
-
|